Image-guided interventional surgery firm Stereotaxis has received the European CE Mark for its Vdrive robotic navigation system.
In addition, the St. Louis-based firm reported that Tamas Szili-Torok, MD, PhD, of Erasmus Medical Center in the Netherlands, successfully used Vdrive to treat atrial fibrillation in a patient with known difficult heart anatomy. In the first human case for Vdrive, Szili-Torok completed the entire case without having to manually adjust the circular mapping catheter, Stereotaxis said.
Stereotaxis' 510(k) application is still under review by the U.S. Food and Drug Administration (FDA).
Related Reading
Stereotaxis signs Siemens, January 10, 2011
Stereotaxis expands catheter partnership, January 5, 2011
Stereotaxis Q3 affected by delays, October 14, 2010
Stereotaxis reports Q4 revenue growth, February 25, 2010
FDA clears Stereotaxis catheter, January 12, 2010
Copyright © 2011 AuntMinnie.com
